Pfizer says its COVID-19 vaccine is safe and works well for kids ages 5–11
Tina Hesman Saey – ScienceNews
How did they find out?
Press Release from Pfizer and BioNTech reporting prelininary data from trials conducted in children age 5-11. Trial enrolled up to 4,500 children ages 6 months to 11 years of age in the United States, Finland, Poland, and Spain from more than 90 clinical trial sites.
Who said so?
Pfizer and BioNTech – producers of the vaccine. Results are not yet published or peer-reviewed.
Who else agrees?
“That preliminary report is promising” – Debbie-Ann Shirley, a pediatric infectious diseases doctor at the University of Virginia in Charlottesville and medical director of the COVID-19 clinic